GRIA2 and Cohen syndrome: In a COH model, treatment with soluble TNF-α induced endocytosis of the AMPA receptor GluA2 subunit in RGCs while activating Ca2+-permeable GluA2-deficient AMPA receptors in RGCs; these changes promoted RGC death [43].